These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2256604)

  • 21. In vitro susceptibility of chloroquine resistant Plasmodium falciparum to mefloquine in Delhi.
    Gajanana A; Sinha S; Vasisth S
    Indian J Malariol; 1986 Dec; 23(2):91-4. PubMed ID: 3552761
    [No Abstract]   [Full Text] [Related]  

  • 22. Status of chloroquine resistance in Plasmodium falciparum in Tripura.
    Dasgupta RK; Misra SP; Nandi J
    Indian J Malariol; 1995 Sep; 32(3):89-92. PubMed ID: 8936289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tropical malaria caused by chloroquine-resistant Plasmodium falciparum, in the Netherlands also a problem of increasing importance].
    Wetsteyn JC; de Geus A
    Ned Tijdschr Geneeskd; 1983 Jul; 127(28):1238-43. PubMed ID: 6350903
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of halofantrine in the treatment of uncomplicated falciparum malaria.
    Mbori-Ngacha DA; Onyango FE; Chunge C; Luta M; Oloo AJ; Muga RO
    East Afr Med J; 1995 Dec; 72(12):796-9. PubMed ID: 8689980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malarial infections caused by Plasmodium falciparum resistant to chloroquine treatment. The situation in Brazil (1960-1981)].
    Reyes S
    Rev Bras Malariol Doencas Trop; 1981; 33():109-30. PubMed ID: 6760261
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment with halofantrine of Plasmodium falciparum malaria imported into France].
    Coulaud JP; Le Bras J; Matheron S; Morinière B; Saimot AG; Rossignol JF
    Bull Soc Pathol Exot Filiales; 1985; 78(5 Pt 2):965-70. PubMed ID: 3915450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A collective malarial infestation during a humanitarian mission in west Africa].
    Philippe JM; Caumon L; Chouaki M; Dufraise S; Rimeize H; Monchard F; Cueto T; Beytout J; Delort P
    Bull Soc Pathol Exot; 2002 Jun; 95(2):71-3. PubMed ID: 12145960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
    Checchi F; Roddy P; Kamara S; Williams A; Morineau G; Wurie AR; Hora B; Lamotte Nd; Baerwaldt T; Heinzelmann A; Danks A; Pinoges L; Oloo A; Durand R; Ranford-Cartwright L; Smet M;
    Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of malaria].
    Boulos M
    Rev Paul Med; 1982; 99(1):29-30. PubMed ID: 6755621
    [No Abstract]   [Full Text] [Related]  

  • 30. Halofantrine in acute malaria.
    Sorabjee JS
    J Assoc Physicians India; 1994 May; 42(5):425. PubMed ID: 7718040
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea.
    Hombhanje FW
    P N G Med J; 1998 Jun; 41(2):51-8. PubMed ID: 10934544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine resistant falciparum malaria--the Indian scene.
    Chogle AR
    J Assoc Physicians India; 1996 Oct; 44(10):677-8. PubMed ID: 9251337
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current therapy and prevention of malaria and perspectives for the future].
    Markwalder K
    Schweiz Med Wochenschr; 1982 Mar; 112(11):362-8. PubMed ID: 7041253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relapse of Plasmodium falciparum malaria after the return from the Ivory Coast. Type R1 halofantrine resistance or successive infections by 2 different strains?].
    Caumes E; Baril L; Danis M; Bricaire F
    Presse Med; 1998 Oct; 27(31):1577-8. PubMed ID: 9819589
    [No Abstract]   [Full Text] [Related]  

  • 35. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
    Kublin JG; Cortese JF; Njunju EM; Mukadam RA; Wirima JJ; Kazembe PN; Djimdé AA; Kouriba B; Taylor TE; Plowe CV
    J Infect Dis; 2003 Jun; 187(12):1870-5. PubMed ID: 12792863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The halofantrine treatment of Plasmodium falciparum malaria. Clinical experience].
    Villota Arrieta J; Barreiro Casal G; García López M; Cilleruelo Ortega MJ; Mellado Peña MJ; Pérez Jurado ML; Martín Fontelos P
    An Esp Pediatr; 1996 Feb; 44(2):117-20. PubMed ID: 8830568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chloroquine resistant Plasmodium falciparum in migrant population.
    Srivastava HC; Sharma SK
    Indian J Malariol; 2000; 37(1-2):39-42. PubMed ID: 11820081
    [No Abstract]   [Full Text] [Related]  

  • 38. Report of a case of P. falciparum malaria resistant to chloroquine and combination of sulfalene and pyrimethamine in Delhi.
    Choudhury DS; Sinha S; Ghosh SK; Devi CU; Sharma VP
    Indian J Malariol; 1987 Jun; 24(1):95-6. PubMed ID: 3326756
    [No Abstract]   [Full Text] [Related]  

  • 39. [Problems of malaria therapy].
    Schelp FP; Germer W
    Dtsch Med J; 1972 Aug; 23(8):529-32. PubMed ID: 4565047
    [No Abstract]   [Full Text] [Related]  

  • 40. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.